Rearming the body’s immune system to fight cancer
We’re developing more precise and more accessible treatment alternatives for patients with solid cancers
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.
Some of our partners
Latest news
Biotech Daily reports ….. Professor Jacques Miller wins Japan prize, January 2018
By carth_admin / May 31, 2018
Professor Jacques Miller a member of Cartherics’ Scientific Advisory Board wins “The Japan Prize Foundation says Walter and Eliza Hall...
Read More
Miltenyi Biotec News ANZ Newsletter : Spring/ Summer 2017
By carth_admin / May 31, 2018
Immunotherapy : Professor Alan Trounson and Professor Richard Boyd started the future of cancer treatment at the Monash Health Translation Precinct.
Read More
Lifesaving ‘off-the-shelf’ cancer tracking immunotherapies underway
By carth_admin / May 30, 2018
29 May 2018, Hudson Institute of Medical Research ‘Off-the-shelf’ immunotherapies to fight aggressive forms of cancer, including relapsed ovarian and...
Read More
